MHB088C

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MHB088C, covering 2025-04-30 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors [Phase 1, Phase 2]